Antitrust in Life Sciences – 3rd Annual Edition
Dina Older Aguilar of Cornerstone Research will speak on a panel titled, “Mergers in the Health Sector” at this annual event.
American Conference Institute: 13th Summit on Biosimilars & Innovator Biologics
Sarah Abraham of Cornerstone Research will speak on a panel titled, “Balancing Innovation and Competition: Patent Thickets, Continued Litigation, and New Economic Considerations for Settlements” at this annual event.
ASHEcon 2022: The Annual Conference of the American Society of Health Economists
Dr. Caitlyn Fleming will discuss “Being a Health Economist: Working in Government, Think Tanks, Health Insurance, Consulting Firms and Pharmaceutical Companies.”
Intersection of Intellectual Property and Competition Policy in Recent Cases
The authors discuss high-profile cases in the EU and US that concern IP rights and competition policy.
Why Curve-Fitting Cannot Be Used to Show Causation or Estimate Impact
Iain Cockburn discusses the problems with curve-fitting methodology in economic analysis in this Westlaw article.
Evaluating Innovation Theories of Harm in Merger Review: Economic Frameworks and Difficulties
The authors discuss recent life science cases that deal with innovation theories of harm, and what economic models can be useful in reviewing proposed mergers in this space.
Federal Trade Commission v. 1-800 Contacts
The Second Circuit Court of Appeals overturned an FTC decision regarding trademark enforcement against online competitors.
Cornerstone Research Staff and Experts Submit Comments to Multilateral Pharmaceutical Merger Task Force
Comments emphasize the need for the FTC to consider the varied effects of mergers on innovation.
Alleged Failure to Disclose Drug Safety Issues
Cornerstone Research was retained by a pharmaceutical company facing securities litigation after it withdrew a drug from the market because of safety concerns.
ICC Arbitration Involving Commercially Reasonable Efforts to Develop and Commercialize a Drug
An ICC arbitration tribunal determined that the claimant did not materially breach its license agreement with the respondent, leaving the agreement in full effect.
How can we help you?
If you are looking for a publication not on our website, contact us.
